Corrigendum to “Efficacy and Safety of Sipjeondaebo-Tang for Anorexia in Patients with Cancer: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial”

Evidence-Based Complementary and Alternative Medicine, Jul 2018

Chunhoo Cheon, Jeong-Eun Yoo, Hwa-Seung Yoo, Chong-Kwan Cho, Sohyeon Kang, Mia Kim, Bo-Hyoung Jang, Yong-Cheol Shin, Seong-Gyu Ko

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

http://downloads.hindawi.com/journals/ecam/2018/6162106.pdf

Corrigendum to “Efficacy and Safety of Sipjeondaebo-Tang for Anorexia in Patients with Cancer: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial”

Corrigendum to “Efficacy and Safety of Sipjeondaebo-Tang for Anorexia in Patients with Cancer: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial” Chunhoo Cheon,1 Jeong-Eun Yoo,2 Hwa-Seung Yoo,2 Chong-Kwan Cho,2 Sohyeon Kang,1 Mia Kim,3 Bo-Hyoung Jang,1 Yong-Cheol Shin,1 and Seong-Gyu Ko1 1Department of Preventive Medicine, Korean Medical College, Kyung Hee University, Seoul, Republic of Korea 2Dunsan Korean Medicine Hospital of Daejeon University, Daejeon, Republic of Korea 3Department of Cardiovascular and Neurologic Disease (Stroke Center), College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea Correspondence should be addressed to Seong-Gyu Ko; rk.ca.uhk@okipe Received 16 May 2018; Accepted 21 June 2018; Published 30 July 2018 Copyright © 2018 Chunhoo Cheon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In the article titled “Efficacy and Safety of Sipjeondaebo-Tang for Anorexia in Patients with Cancer: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial” [1], there was an error in the conclusion of the Abstract where the text reading “Sipjeondaebo-tang appears to have potential benefit for anorexia management in patients with cancer. Further large-scale studies are needed to ensure the efficacy” should be corrected to “In the present study, Sipjeondaebo-tang did not show a significant effect on anorexia in patients with cancer. Further large-scale studies which compensate for the limitations of this study are needed to assess the efficacy”. This error in the reporting was brought to the attention of the journal by Professor Edzard Ernst, Emeritus Professor of Complementary Medicine, University of Exeter. The journal and the authors apologize for this misreporting of the conclusions. References C. Cheon, J. Yoo, H. Yoo et al., “Efficacy and Safety of Sipjeondaebo-Tang for Anorexia in Patients with Cancer: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, Article ID 8780325, 9 pages, 2017. View at Publisher · View at Google Scholar


This is a preview of a remote PDF: http://downloads.hindawi.com/journals/ecam/2018/6162106.pdf

Chunhoo Cheon, Jeong-Eun Yoo, Hwa-Seung Yoo, Chong-Kwan Cho, Sohyeon Kang, Mia Kim, Bo-Hyoung Jang, Yong-Cheol Shin, Seong-Gyu Ko. Corrigendum to “Efficacy and Safety of Sipjeondaebo-Tang for Anorexia in Patients with Cancer: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial”, Evidence-Based Complementary and Alternative Medicine, 2018, DOI: 10.1155/2018/6162106